# Vortioxetine in Patients With Depression and Early Dementia

> **NCT04294654** · PHASE4 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 82 (actual)

## Conditions studied

- Major Depressive Disorder
- Dementia

## Interventions

- **DRUG:** Vortioxetine

## Key facts

- **NCT ID:** NCT04294654
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-28
- **Primary completion:** 2022-07-06
- **Final completion:** 2022-07-20
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2022-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04294654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04294654, "Vortioxetine in Patients With Depression and Early Dementia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04294654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*